|Videos|August 3, 2017
What is the Goal of Treat-to-Target in Patients with Rheumatoid Arthritis?
What is the importance and prevalence of treat-to-target?
Advertisement
Marcus H. Snow, MD, from University of Nebraska Medical Center, speaks about the importance of treat-to-target and its goal of disease remission in patients with rheumatoid arthritis. Dr. Snow believes that most physicians already practice an informal treat-to-target therapy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Positive Phase 2a Trial Supports FDA Clearance of StemCyte’s HPC Therapy for Long COVID Patients
2
Centanafadine for Treatment of ADHD in Children, Adolescents, and Adults Accepted By FDA for Priority Review
3
Carbachol and Brimonidine Tartrate Combination Eye Drop Receives FDA Approval for Presbyopia
4
Plant-Based Foods, Even If Ultra-Processed, Can Reduce Risk of Diabetes
5